ArticleClinical and translational science2024
Correction to Pharmacokinetics and pharmacodynamics of itepekimab in adults with moderate-to-severe atopic dermatitis: Results from two terminated phase II trials.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.